The star-allele nomenclature: Retooling for translational genomics

Clinical Pharmacology and Therapeutics

Volumn 82, Issue 3, 2007, Pages 244-248

  Robarge, J D ^a   Li, L ^a   Desta, Z ^a   Nguyen, A ^a   Flockhart, D A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN GENOME; NOMENCLATURE; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; GENOMICS; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN BIOSYNTHESIS; TERMINOLOGY;

EID: 34547917189     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100284     Document Type: Review

References (10)

1. Alexanderson, B., Evans, D.A. & Sjöqvist, F. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br. Med. J. 4, 764-768 (1969).
2. Mahgoub, A., Idle, J.R., Dring, L.G., Lancaster, R. & Smith, R.L. Polymorphic hydroxylation of debrisoquine in man. Lancet 2, 584-586 (1977).
3. Eichelbaum, M., Spannbrucker, N. & Dengler, H.J. Proceedings: N-oxidation of sparteine in man and its interindividual differences. Naunyn Schmiedebergs Arch. Pharmacol. 287, Suppl:R94 (1975).
4. Gonzalez, F.J., Skoda, R.C., Kimura, S., Umeno, M., Zanger, U.M., Nebert, D.W. et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331, 442-446 (1988).
5. Nebert, D.W. Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology. Pharmacogenetics 10, 279-290 (2000).
6. Sim, S.C. & Ingelman-Sundberg, M. The human cytochrome P450 Allele Nomenclature Committee Web site: submission criteria, procedures, and objectives. Methods Mol. Biol. 320, 183-191 (2006).
7. Klein, T.E. et al. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J. 1, 167-170 (2001).
8. Kruglyak, L., Daly, M.J., Reeve-Daly, M.P. & Lander, E.S. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58, 1347-1363 (1996).
9. Stephens, M., Smith, N.J. & Donnelly, P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978-989 (2001).
10. Sconce, E., Khan, T.I., Wynne, H.A., Avery, P., Monkhouse, L., King B.P. et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Blood 106, 2329-2333 (2005).